KR20080105825A - Herb composition useful for arthritis treatment or prevention and preparation thereof - Google Patents

Herb composition useful for arthritis treatment or prevention and preparation thereof Download PDF

Info

Publication number
KR20080105825A
KR20080105825A KR1020070053892A KR20070053892A KR20080105825A KR 20080105825 A KR20080105825 A KR 20080105825A KR 1020070053892 A KR1020070053892 A KR 1020070053892A KR 20070053892 A KR20070053892 A KR 20070053892A KR 20080105825 A KR20080105825 A KR 20080105825A
Authority
KR
South Korea
Prior art keywords
weight
arthritis
bark
root
herbal
Prior art date
Application number
KR1020070053892A
Other languages
Korean (ko)
Inventor
김선정
Original Assignee
김선정
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김선정 filed Critical 김선정
Priority to KR1020070053892A priority Critical patent/KR20080105825A/en
Publication of KR20080105825A publication Critical patent/KR20080105825A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/46Eucommiaceae (Eucommia family), e.g. hardy rubber tree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/21Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284Atractylodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/716Clematis (leather flower)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps

Abstract

A herb medicine composition for treating and preventing arthritis, and a method for preparing the herb medicine composition are provided to reduce side effect and to improve the convenience and safety of medicine taking. A herb medicine composition for treating and preventing arthritis is prepared by extracting 20 wt% of Eucommiae cortex, 20 wt% of Angelica gigas Nakai, 15 wt% of Achyrantis Radix, 15 wt% of Atractyodis Rhizoma, 10 wt% of Clematidis Radis, 5 wt% of Commiphora myrrha ENGL., 5 wt% of Kalopanax ricinifolium, 5 wt% of Angelica pubescens MAXIM. and 5 wt% of the bark of a willow, and fermenting the extracted one.

Description

관절염 치료 및 예방용 생약조성물 및 그 제조방법{Herb composition useful for arthritis treatment or prevention and preparation thereof}Herb composition useful for arthritis treatment or prevention and preparation

본 발명은 관절염 예방 및 치료에 탁월한 효과를 보이는 복합 생약재로부터 유효활성 성분을 추출 및 발효 정제하는 방법과 그 추출물을 함유한 생약조성물 및 이를 이용한 관절염 예방 및 치료법에 관한 것이다. 보다 상세하게는 우슬, 창출,당귀, 두충, 위령선, 몰약, 독활 등 9가지 생약재를 적정비로 혼합하여 열수 혹은 알코올성 수용액으로 추출한 후 여과하여 Acetobacter 균류, 또는 누룩 등을 이용하여 발효한 후 정제 농축하여 얻어진 발효산물의 조성물로서 관절보호효과를 가지는 관절염 치료 약제 조성물과 그 제조방법에 관한 것이다.The present invention relates to a method for extracting and fermenting an active ingredient from a complex herbal medicine showing an excellent effect on preventing and treating arthritis, a herbal composition containing the extract, and a method for preventing and treating arthritis using the same. More specifically, nine herbal medicines such as hyssop, creation, donkey, tofu, gastrointestinal tract, myrrh, and poisonous extract are mixed at an appropriate ratio, extracted with hot water or alcoholic aqueous solution, filtered, fermented with Acetobacter fungus, or yeast, and concentrated. It relates to a pharmaceutical composition for treating arthritis having a joint protective effect as a composition of the obtained fermentation product and a method for producing the same.

일반적으로, 관절염은 크게 골관절염(퇴행성 관절염,Osteoarthritis)과 류마티스 관절염(Rheumatoid arthritis)으로 구분되며, 관절염 및 관절 염증 관련 질환은 다양한 형태로 발생한다.In general, arthritis is largely divided into osteoarthritis (Osteoarthritis) and rheumatoid arthritis, arthritis and joint inflammation-related diseases occur in various forms.

관절염은 특히 관절낭 내층의 활액막에 염증성 변화로 특징지어지는 만성 다 관절염으로써 전신의 관절에서 부종과 통증이 유발되고, 심각한 경우에는 신체장애 자가 될 수 있는 만성적으로 진행되는 질환이다. 또한 류마티스 관절염과 같은 관절염 질환은 진행성이고 변형 및 관절 불굴과 같은 관절장애를 발생시켜, 종종 효과적인 치료의 결핍과 계속된 악화로 인한 심각한 고통으로 육체적 장애를 일으킨다.Arthritis is a chronic polyarthritis characterized by inflammatory changes, especially in the synovial membrane of the lining of the articular capsule. It is a chronically advanced disease that causes swelling and pain in the joints of the whole body and, in severe cases, can cause disability. Arthritis diseases, such as rheumatoid arthritis, are also progressive and develop joint disorders such as deformation and joint instability, often causing physical disability with severe pain due to lack of effective treatment and continued exacerbation.

관절염이 유발되는 직접적인 원인은 아직까지 명확하지 않고 이에 대해 계속적으로 연구가 진행되고 있으며, 현재까지 류마티스 관절염 등의 관절염의 효과적인 예방법은 알려진 바 없고, 일단 발병이 되는 경우에도 그의 치료를 위해 해결해야 할 점들이 많이 남아 있다.The direct cause of arthritis is not clear yet, and research on this is ongoing. Effective prevention of arthritis such as rheumatoid arthritis has not been known until now. There are many points left.

전통적으로 이러한 관절염의 치료에는 코르티손 및 다른 부신피질 호르몬과 같은 스테로이드게, 아스피린, 피록시캄 및 인도메타신과 같은 비스테로이드계 항염증제, 오로타이오능금산과 같은 금작용제, 클로로퀴논제제 및 D-페니실아민과 같은 항류마티스제, 콜치신과 같은 통풍억제제, 및 시클로포스프아미드, 아자티오프린, 메토트렉세이트 및 레바미솔과 같은 면역 억제제를 포함하여 다양한 작용제로 화학요법으로 치료되어왔다.Traditionally, these arthritis treatments include steroid crabs, such as cortisone and other corticosteroids, nonsteroidal anti-inflammatory agents, such as aspirin, pyroxam, and indomethacin, gold agonists, such as orothioactive acid, chloroquinones, and D-penny Chemotherapy has been treated with various agents including antirheumatic agents such as silamine, gout inhibitors such as colchicine, and immunosuppressants such as cyclophosphamide, azathioprine, methotrexate, and levamisol.

위에서 언급한 치료제들은 근원적인 치료법이 아니며, 스테로이드 호르몬제가 관절염 치료제로 알려지면서 많이 사용되기도 했으나, 그 부작용이 명백해짐에 따라 그 사용은 어렵게 되었다.The treatments mentioned above are not a fundamental treatment, and steroid hormones have been widely used as arthritis treatments, but as the side effects become obvious, their use has become difficult.

또한, 관절염, 특히 만성 류마티스 관절염은 환자에게 심한 통증을 유발하므로 반드시 항염증제 등을 복용하여야만 하며, 지금까지 이러한 통증을 완화시키거나 관절의 종창을 제거하는 약제로서 아스피린제 및 브타졸린제 등이 오랫동안 널 리 사용되어 왔다. 그러나 아스피린 등은 사람의 위에 치명적인 영향을 주므로 관절염을 치료하는데 필요한 양을 계속적으로 복용하는 것은 어렵다.In addition, since arthritis, especially chronic rheumatoid arthritis, causes severe pain in patients, it is necessary to take anti-inflammatory drugs, etc. Until now, aspirin and betazoline drugs have been used for a long time to alleviate such pain or to remove joint swelling. Has been used. However, aspirin and the like have a fatal effect on the stomach, so it is difficult to continue taking the amount needed to treat arthritis.

기존의 이러한 화학요법적 약제는 약제의 장기간 사용을 방해하는 부작용, 항염증 효과의 결핍, 및 이미 발생한 관절염에 대한 효능의 부족과 같은 결점을 가지고 있으며, 현재 관절염 치료에 진통작용이 우수한 인도메타신 및 푸르페낭산과 비스테로이드성의 각종 소염제 정도가 조제하여 사용되고 있는 실정이다.Existing chemotherapeutic agents have drawbacks such as side effects that hinder the long-term use of the drugs, lack of anti-inflammatory effects, and lack of efficacy against arthritis that has already occurred, and indomethacin, which is currently effective in treating arthritis. And furphenic acid and various non-steroidal anti-inflammatory agents are used in preparation.

따라서, 이러한 문제에 대한 해결책과 급성 염증성 증상과 고통에 대해 증상적인 효과를 보여주는 관절염 치료제의 개발이 요구되고 있으며, 현재 사용되고 있는 대부분의 관절염 치료제는 정도의 차이나 개인적인 있기는 하지만, 모두 어느 정도의 부작용을 가지고 있고, 특히 류마티스 관절염의 치료를 위해서는 약제를 장기간 복용할 필요가 있기 때문에, 부작용이 적은 약재를 개발하는 것이 매우 중요하다.Thus, there is a need for solutions to these problems and the development of arthritis medications that have symptomatic effects on acute inflammatory symptoms and pain, and most of the arthritis medications currently in use are somewhat different, but all have some side effects. In order to treat rheumatoid arthritis, especially since it is necessary to take a long time, it is very important to develop a medicine with less side effects.

또한 상기 약재 중 일부는 정맥 주사나 복강 주사로 투여하는 경우가 있는데, 이 경우에는 번거로울 뿐 아니라 반복된 정맥주사 등은 앨러지, 쇼크 뿐 아니라, 위생상의 문제도 생길 수 있다. 따라서 복용하기에 간편하면서 안전한 치료제가 요구되고 있다.In addition, some of the medicine may be administered by intravenous injection or intraperitoneal injection, in which case it is not only cumbersome but repeated intravenous injection may cause allergy, shock as well as hygiene problems. Therefore, there is a need for a simple and safe treatment.

따라서 본 발명의 목적은 부작용이 적고 복용이 간편하며 안전한 관절염 치료용 생약조성물 및 그 제조방법을 제공하는 데에 있다. Accordingly, an object of the present invention is to provide a herbal composition for treating arthritis and a method of preparing the same, which have fewer side effects and are easy to take.

상기한 목적을 달성하기 위한 본 발명자의 연구에서 두충, 우슬, 당귀, 창출, 위령선, 몰약, 독활 등 9가지 생약재로부터 각각의 특성과 효능을 최대한 살리고 관절염에 대한 치료효과 특히, 발효과정을 통하여 인체의 흡수율을 높여 연골 보호 작용을 최대한 극대화시켜 한방 생약의 원리에 근거한 거풍습, 강근골, 활혈 및 조직재생 촉진 작용을 중심으로 여러 종류의 생약들 중 독성이 가장 없어 일반 식품으로도 사용이 가능하여 부작용 또한 거의 없는 이들을 선정하여 생약원료의 발효 과정을 바탕으로 관절염 치료에 대한 검정 실험을 거쳐 만족할만한 관절염 치료 및 예방에 효과가 있는 생약들을 선택하여 발효 방법을 통해 본 발명을 완성하게 되었다.In the study of the present inventors to achieve the above object, to maximize the characteristics and efficacy of each of the nine herbal medicines, such as worms, hyssop, Angelica, creation, gastric, myrrh, poisonous activity and to treat arthritis, in particular, through the fermentation process It maximizes cartilage protection by maximizing absorption of cartilage, and it can be used as a general food because it has the least toxicity among various kinds of herbal medicines based on the principle of herbal medicine, hard muscle bone, blood circulation and tissue regeneration. Those who have almost no side effects are also selected, and through the fermentation process of the herbal medicine raw materials through a test experiment for the treatment of arthritis to select satisfactory herbal medicine that is effective in the treatment and prevention of arthritis to complete the present invention through the fermentation method.

본 발명에 의하면 두충 수피 20중량%, 당귀 뿌리 20중량%, 우슬 뿌리 15중량%, 창출 뿌리줄기 15중량%, 위령선 뿌리 10중량%, 몰약 5중량%, 엄나무 줄기의 속껍질 5중량%, 독활 5중량% 및 버드나무 수피 5중량%를 동시에 추출하거나 또는 각각 추출하여 발효시킨 관절염 치료 및 예방용 생약조성물이 제공된다. According to the present invention 20% by weight bark bark, 20% by weight of Angelica root, 15% by weight of root, 15% by weight of root generation, 15% by weight of roots, 5% by weight of myrrh root, 5% by weight of myrrh stem, 5% by weight of oak stem, poison 5 Provided is a herbal composition for treating and preventing arthritis, which is simultaneously extracted or 5% by weight of willow bark is extracted or fermented, respectively.

또한 본 발명에 의하면 두충 수피 20중량%, 당귀 뿌리 20중량%, 우슬 뿌리 15중량%, 창출 뿌리줄기 15중량%, 위령선 뿌리 10중량%, 몰약 5중량%, 엄나무 줄기의 속껍질 5중량%, 독활 5중량% 및 버드나무 수피 5중량%를 동시에 추출하거나 또는 각각 추출하여 혼합하는 생약추출단계 및 얻어진 추출액의 발효단계를 포함하는 관절염 치료 및 예방용 생약조성물의 제조방법이 제공된다. In addition, according to the present invention, 20% by weight of bark larvae, 20% by weight of Angelica root, 15% by weight of roots, 15% by weight of rhizome stems, 10% by weight of lichen roots, 5% by weight of myrrh, 5% by weight of the bark of the oak stem, poisonous Provided is a method for producing a herbal composition for the treatment and prevention of arthritis, including a herbal extract step of simultaneously extracting 5% by weight and 5% by weight of willow bark, or by separately extracting and fermenting the obtained extract.

또한 본 발명에 의하면 상기한 발효단계에서 발효된 추출액을 농축하는 단계를 더 포함하는 생약조성물의 제조방법이 제공된다. In addition, according to the present invention there is provided a method for producing a herbal composition further comprising the step of concentrating the extract fermented in the fermentation step.

이하, 본 발명을 상세하게 설명하기로 한다. Hereinafter, the present invention will be described in detail.

본 발명에서 사용되는 주성분인 두충, 우슬, 당귀, 창출, 위령선, 몰약, 독활 등 9가지 생약재 들은 일반적으로 한방에서 널리 잘 알려져 있을 뿐만 아니라 발효과정을 거쳐 독성 등의 부작용이 거의 없는 특징을 갖고 있다. Nine herbal medicines, including the main components used in the present invention, such as tofu, dew, donkey, creation, gastric, myrrh, poison, etc., are generally well known in oriental medicine and have almost no side effects such as toxicity through fermentation. .

이들 각각의 생약들의 특성과 구체적인 작용을 알아보면 다음과 같다.The characteristics and specific actions of each of these herbs are as follows.

당귀(當歸, Dong quai) 또는 미나리과(Umbelliferae)의 참당귀(Angelica gigas NAKAI)의 뿌리를 건조한 것을 일컫는 것으로, 중국에서는 당귀(Angelica sinensis DIELS)의 뿌리를 건조한 것을 사용하며, 일본에서는 일당귀(Angelica acutiloba KITAGAWA)의 뿌리를 건조한 것을 사용해 왔다. 당귀는 보혈, 활혈의 효능과 허를 보충하는 작용으로 혈병의 요약으로서 부인의 산후병, 빈혈, 두통 등의 치료에 효과적으로 처방되어 왔다.(상용약용식물도감, 박종희, 이정규 공저, 신일상사, pp409-411, 2000; 중약본초학, 보건신문사, pp684-686, 1998).It refers to dried root of Angelica gigas NAKAI of Dong quai or Umbelliferae. In China, dried root of Angelica sinensis DIELS is used. In Japan, Angelica acutiloba is used. KITAGAWA) roots have been used to dry. Angelica is effective in the treatment of women's postpartum disease, anemia, headache, etc. as a summary of blood clots, as a supplement to the effects and heuristic of blood and blood. (Commercial Plant Book, Jong-Hee Park, Jung-Kyu Lee, Shin Il-Sang, pp409- 411, 2000; Chinese Herbal Medicine, Health Newspaper, pp684-686, 1998).

두충(杜沖, Hardy Rubber Tree)은 쌍떡잎식물 장미목 두충과의 낙엽활엽 (Eucommia ulmoides) 식물로서, 중국 특산식물이며 한방에서는 간신의 기능부족으로 나타나는 요통과 무릎이 시리고 연약해지는 증상 등에 근육의 탄력을 강화시키면서 골질 형성을 촉진시킨다. 나무껍질을 보약·강장제로 쓰고, 대뇌를 튼튼하게 하며, 폐와 무릎앓이·음습증을 다스린다. 민간에서는 잎을 달여서 신경통·고혈압 에 쓰고 차로도 복용한다.(김창민 외, 원색 한약도감, 아카데미서적 ,190p, 2001 ; 현대생약학. 학창사. 1991 ; 안덕균, 원색 한국본초도감. 교학사. 1998 ; 이영노, 원색한국식물도감. 교학사. 1996 ; 이우철, 원색한국기준식물도감. 아카데미서적. 1996 ; 이창복, 대한식물도감. 향문사. 1979 ; 정태현, 한국식물도감. 신지사 1958 ; 지형준, 한약(생약)규격집 주해서, 한국메디칼인덱스사, 489p, 1998 ; 안덕균, 한국본초도감, 교학사, 670p, 2000 ; 홍원식, 약초의 성분과 이용, 일월서각, 177p, 1999).Hardy Rubber Tree is a deciduous broad-leaved (Eucommia ulmoides) plant of the dicotyledonous rose family, which is a plant native to China. Promotes bone formation while strengthening. The bark is used as a medicine and tonic, strengthens the cerebrum, and manages lung and knee ailments and groin. In the private sector, the leaves are used for neuralgia and hypertension, and they are also taken as tea. (Chang Chang-min et al., Primary Herbal Medicine Book, Academic Book, 190p, 2001; Modern Pharmacy, Hakchangsa. 1991; Ahn Deokgyun, Primary Korean Color Book. , Korean Color Book of Korean Plants and Teachers, 1996; Lee Woo-Chul, Color Book of Korean Standard Plants, Academy Books 1996; Lee Chang-bok, Korean Flower Books, Hyangmunsa, 1979; Jeong Tae-hyun, Korean Flower Books, Shinjisa 1958; Notes, Korean Medical Index, 489p, 1998; Ahn Deok-gyun, Korea Herbal Book, Kyohaksa, 670p, 2000; Hong Won-sik, Ingredients and Utilization of Medicinal Herbs, Ilwol Seokje, 177p, 1999).

우슬(牛膝, Japanese Achyranthes)은 우리나라에서는 비름과의 쇠무릎(Achyranthes japonica Nakai) 또는 우슬(Acyranthes bidentata Blume:牛膝)의 뿌리를 말하며, 일본에서는 우슬(Acyranthes bidentata Blume:牛膝)과 털쇠무릎(Achyranthes fauriei H. Lev. & Vaniot)을 쓴다. 중국은 우슬(Acyranthes bidentata Blume:牛膝)만을 인정하고 있다. 한방과 민간에서 각기, 정혈, 보익, 관절염, 통풍, 이뇨, 신견통, 통경, 어혈 등에 약재로 쓰인다. 임질, 혈뇨, 월경폐지, 산후어혈로 인한 복통, 무릎의 통증, 타박상 등에 효과가 있다. 뿌리의 알코올 및 물 추출액은 동물 실험에서 자궁 수축 작용이 뚜렷하다. 그 작용은 특히 수태 말기와 산욕기 자궁에서 세게 나타난다. (홍원식, 약초의성분과이용, 일월서각, 222p, 1999 ; 이영노, 한국식물도감, 교학사, 434p, 1998 ; 두산세계대백과 encyber ; 가공식품의 원료로 사용할 수 있는 동식물범위에 관한 연구, 한국식품공업협회 한국식품연구소, 323p, 1994 ; 김태정, 한국의 야생화, 교학사, 336p, 2001).Japanese Achyranthes refers to the roots of Achyranthes japonica Nakai or Acyranthes bidentata Blume (牛膝) in Korea, and in Japan, Acyranthes bidentata Blume (牛膝) and hairy knee (털) in Japan. Achyranthes fauriei H. Lev. & Vaniot). China recognizes only Acyranthes bidentata Blume. In oriental medicine and private medicine, it is used for medicines such as blood, bowel, arthritis, gout, diuresis, canine pain, pain, and blood. It is effective for gonorrhea, hematuria, abolition of menstruation, abdominal pain due to postpartum blood, pain in the knee, and bruises. Alcohol and water extracts from the roots have pronounced uterine contractions in animal experiments. Its action is particularly intense in the late conception and in the uterus. (Hong Won-sik, Ingredients and Utilization of Herbs, Ilwol Seokgak, 222p, 1999; Lee Young-no, Korea Book of Plants, Kyohaksa, 434p, 1998; Doosan World Daebaekwa encyber; Studies on the range of animals and plants that can be used as raw materials for processed foods, Korea Food Industry Korean Food Research Institute, 323p, 1994; Kim, Tae-Jung, Wildflowers, Kyohaksa, 336p, 2001).

창출(蒼朮, Atractylodis Rhizoma) 국화과(Atractylodes japonica)의 쌍떡잎식물 초롱꽃목 국화과의 여러해살이풀로, 발한·이뇨·진통·건위 등에 효능이 있어 식욕부진·소화불량·위장염·감기 등에 사용한다.(두산세계대백과 encyber ; 박종희 외, 상용약용식물도감, 신일상사, 208p, 2000).It is a perennial plant of Atractylodes japonica, a dicotyledon of the Atractylodes japonica, and it is effective for sweating, diuresis, analgesia, dryness, etc. World Encyclopaedia encyber; Park Jong-Hee et al., Commercial Medicinal Plants Book, Shinil Corporation, 208p, 2000).

위령선(威靈仙, Clematidis Radix)은 쌍떡잎식물 미나리아재비목 미나리아재비과(Clematis mandshurica var. koreana)의 덩굴성 여러해살이풀로 풍습을 제거하고 통증을 가라앉히므로 관절의 굴신불리, 사지마비, 요통과 다리의 동동, 근육마비 등을 풀어주며, 타박상으로 동통이 지속될 때에도 쓰인다.(지형준, 한약(생약)규격집 주해서, 한국메디칼인덱스사, 290p, 1998 ; 안덕균, 한국본초도감, 교학사, 304p. 2000 ; 홍원식, 약초의 성분과 이용, 일월서각, 281p, 1999 ; http://www.tradimed.co.kr/htrad/drug.asp ; H.K. Do, Shin Rhong Bon Cho Kyung, 452).Clematidis Radix is a vine perennial herb of Clematis mandshurica var. Koreana, which removes customs and soothes pains. It is used to relieve pain and muscle paralysis of legs, and also when pain persists due to bruises. (Hyung-Joon Ji, Herbal Medicine (Medicinal Herbs) Standard Collection), Korea Medical Index, 290p, 1998; Hong Won-sik, Ingredients and Utilization of Herbs, Ilwol Seokgak, 281p, 1999; http://www.tradimed.co.kr/htrad/drug.asp; HK Do, Shin Rhong Bon Cho Kyung, 452).

몰약 (沒藥, myrrh)은 미르라(myrrha)라고도 한다. 염료에 사용되는 화몰약(花沒藥)과 구별하기 위하여 연몰약(練沒藥)이라고도 한다. 아프리카 ·아라비아 지방에 자생하는 감람과식물인 콤미포라 미르라(C.myrrha)나 콤미포라 아비시니카(C.abyssinica) 등의 수피(樹皮)에 상처를 내어 채취한 천연고무수지로 어혈(瘀血)정체로 인한 부인의 생리통, 무월경, 산후 복통, 복부 통증을 치료한다. 타박상으로 혈액이 울체되어 지속적인 통증이 일어나는 증상을 완화시킨다. 풍습(風濕)으로 인한 사지마비 동통, 관절염 등에 널리 사용된다. 피부궤양이 오래도록 치유되지 않는 것을 다스린다.(안덕균, 한국 본초도감, 교학사, 568p, 2000 ; 김창민외2, 원색 한약도감, 아카데미서적, 307p, 2001 ; 가공식품의 원료로 사용할 수 있는 동식물범위에 관한 연구, 한국식품공업협회 한국식품연구소, 144p, 1994 ; 장상문외 5인 공저. 한약자원식물학, 학문출판, 523p, 1996 ; 지형준, 한약(생약)규격집 주해서, 한국메디칼인덱스사, 233p, 1998).Myrrh (沒 藥, myrrh) is also called myrrha. It is also called a lotus flower to distinguish it from the hay flock used in dyes. It is a natural rubber resin obtained by wounding bark such as C. myrrha or C. abyssinica, an olive and plant native to Africa and Arabia.血) to treat dysmenorrhea, amenorrhea, postpartum abdominal pain, abdominal pain due to congestion. The bruise causes the blood to linger and relieve the symptoms of persistent pain. It is widely used for quadriplegia pain and arthritis due to the custom. Treats skin ulcers that do not heal for a long time. (Andeokgyun, Korea Herbal Painting, Kyohaksa, 568p, 2000; Kim, Changmin et al. 2, Primary Color Herbal Medicine, Academy Book, 307p, 2001; A Study, Korea Food Research Institute, Korea Food Research Institute, 144p, 1994; co-authored by Jang Sang-moon et al. Medicinal Herbal Botanicals, Academic Publishing, 523p, 1996; ).

엄나무(Caster Aralia 음나무)는 두릅나무과(Kalopanax pictus)의 쌍떡잎식물 산형화목 두릅나무과의 낙엽교목이다. 생약(生藥)에서 봄과 여름에 줄기겉껍질을 벗겨버리고 속껍질을 벗겨 햇볕에 말려 약재로 쓴다. 한방에서 수피, 근피를 거담, 진통 등에 약재로 쓰며 민간에서는 껍질과 잎을 피부병, 궤양, 전염성상처 때 쓴다. 사지마비와 환부 치료약으로 사용했다.(한국산 두릅나무과의 화분분류학적 연구, 식물분류학회지 19: 103-121, 1989, ; 원색한국기준식물도감, 아카데미서적, 1996 ; 원색한국식물도감, 교학사, 1996 ; 원색한국본초도감, 교학사, 1998 ; 한국의 나무문화, 문예산책, 1996 ; 원색한약도감, 아카데미서적, 197, 2001).The moss (Caster Aralia) is a deciduous tree of the dicotyledon of the Kalopanax pictus. Peel off the outer skin of the stem in spring and summer, peel off the inner skin and dry it in the sun to use as a medicinal herb. In Chinese medicine, bark, root bark is used as medicine for expectoration, pain, etc. In civilian use, peels and leaves are used for skin diseases, ulcers, and infectious wounds. It was used as a medicine for treating quadriplegia and lesions. (Potonic Taxonomic Study of Korean Elmaceae, Journal of Plant Classification, 19: 103-121, 1989,; Color Book of Korean Standard Plants, Academy Book, 1996; Color Book of Korean Plants, Kyohaksa, 1996 ; Primary Color Book of Korea, Teaching History, 1998; Korean Tree Culture, Book of Art, 1996; Primary Color Book, Academy Book, 197, 2001).

독활((獨活, Aralia continentalis Kitagawa)의 뿌리를 사용하여 만든 약재(한국). 중국은 중치모당귀(Angelica pubescens Maxim. f. biserrata Shan et Yuan:重齒毛當歸)를 쓴다. 일본은 땅두릅(Aralia cordata Thunb.)의 뿌리줄기를 독활(獨活)로 사용하고 있다. 풍한습이 원인이 되어 발병한 근육통, 관절염, 요통, 무릎과 하지의 동통 및 무력증에 쓰이고, 조습작용이 있어서 피부가려움증을 치료한다. 외감성으로 인한 발열, 오한, 두통, 사지통 등에 널리 활용되며, 산종 작용이 있어서 종기를 치료한다.(김창민, 원색한약도감, 34p, 아카데미서적, 2001 ; 안덕균, 원색한국본초도감, 교학사, 33p, 2000 ; 김태정, 쉽게 찾는 우리나물, 현암 사, 100p, 2001 ; 지형준, 한약(생약)규격집주해서, 한국메디칼인덱스사, 185p, 1998).Medicinal herbs (Korea) made from the roots of the poisonous leaf (Aralia continentalis Kitagawa). China wears Angelica pubescens Maxim.f.biserrata Shan et Yuan (Japan). The root stem of Aralia cordata Thunb.) Is used as a poison, and is used for myalgia, arthritis, low back pain, pain and weakness of the knee and lower limb caused by abundant humidity, and itching and skin itching. It is widely used in fever, chills, headache, limb pain due to externality, and it treats boils due to acidic effect. (Kim Chang-min, primary color map, 34p, academy book, 2001; 33p, 2000; Kim, Tae-Jung, Korean Herb, Easily Finding, Hyeonamsa, 100p, 2001; Koh Jun-jun, Medicinal Herbs (Medicinal Herbs) Standard, Korea Medical Index, 185p, 1998).

버드나무(willow)는 쌍떡잎식물 버드나무목 버드나무과(Salix koreensis Anderss)의 낙엽교목이다. 감기 몸살과 같이 열을 동반하는 가벼운 증상에 그리고 급만성 류마티즘 및 가벼운 증상의 두통과 염증으로 인한 통증을 완화하는데 좋은 효과가 있다(이영노, 원색한국식물도감, (주)교학사, 51p, 1998 ; 두산세계대백과 엔싸이버 ; http://www.herbnhealth.co.kr/herbindex/willow.html).Willow is a deciduous tree of the salix koreensis Anderss. It has a good effect on mild symptoms such as cold body pain and fever caused by headaches and inflammation of acute rheumatism and mild symptoms (Lee Young-no, Color Book of Korea Botany, Kyohaksa, 51p, 1998; Doosan World White Encyclopedia; http://www.herbnhealth.co.kr/herbindex/willow.html).

이상과 같이 이들 각각의 생약들은 각종 상처나 종기, 만선염증과 빈혈, 두통, 감기 및 신경통, 관절염, 타박상에 일반적으로 사용되는 생약들로 구성되어 있으며, 각각의 생약재들은 고유한 약리작용 및 주 효능을 지니고 있다. 그러나 지금까지는 이들 각각의 생약들은 단방 생약으로서의 효능과 유효성분 분리 및 제조방법에 대해서만 연구되어 왔으며, 또한 간혹 몇 가지 약재들은 혼합하여 사용해 관절염에 대한 치료효과를 버려는 시도가 있었지만 이들이 관절염 치료에 대한 약효가 과학적으로 입증될 만한 것이 못 되었고 그 효과도 미비하였다. 더구나 관절염 치료의 핵심인 관절의 연골과 조직을 보호 유지시키고 재생시키는 것에 초점이 맞추어져 있지 않았다.As mentioned above, each of these herbal medicines is composed of herbal medicines commonly used in various wounds or boils, pancreatitis and anemia, headache, cold and neuralgia, arthritis and bruise, and each herbal medicine has unique pharmacological action and main effect. It has However, until now, each of these herbal medicines has been studied only for its efficacy as a one-way herbal medicine and for the method of separating and preparing the active ingredients, and in some cases, some herbal medicines have been mixed and used to obtain a therapeutic effect on arthritis. The efficacy was not scientifically proven and the effect was insignificant. Moreover, the focus was not on protecting and regenerating the cartilage and tissue of the joints, which are the core of arthritis treatment.

본 발명에 사용되는 생약재는 두충의 수피, 당귀의 뿌리, 우슬의 뿌리, 창출의 뿌리줄기, 위령선의 뿌리, 몰약, 엄나무 줄기의 속껍질, 독활 및 버드나무 수피이다. The herbal medicines used in the present invention are the bark of the larvae, the root of the Angelica, the root of the dew, the rhizome of the creation, the root of the lichen, the myrrh, the bark of the oak stem, the poisonous tree and the willow bark.

본 발명에 사용되는 생약재의 비율은 수분함량 15% 이하의 건조 생약재인 두 충 수피 20중량%, 당귀 뿌리 20중량%, 우슬 뿌리 15중량%, 창출 뿌리줄기 15중량%, 위령선 뿌리 10중량%, 몰약 5중량%, 엄나무 줄기의 속껍질 5중량%, 독활 5중량% 및 버드나무 수피 5중량%이다. 상기한 중량비는 수분함량 15% 이하의 건조된 생약기준이다. The ratio of the herbal medicine used in the present invention is 20% by weight of dried medicinal herb bark, 20% by weight of Angelica root, 20% by weight of root, 15% by weight of root, 15% by weight of rhizome, 10% by weight of lichen root, 5% by weight of myrrh, 5% by weight of the bark of the oak stem, 5% by weight of poison and 5% by weight of the bark of willow. The above weight ratios are based on dried herbal medicines with a water content of 15% or less.

바람직하게 생약들은 5 내지 10배, 더욱 바람직하게는 10 내지 15배 부피/중량의 증류수, 에탄올 등과 같은 저급 알코올 또는 이들의 혼합용매, 바람직하게는 증류수 단독 또는 30 내지 50% 물과 에탄올의 혼합용매를 가하여, 15℃ 이하 내지 실온에서 12시간 내지 24시간, 바람직하게는 24시간 내지 36시간 냉침한 후, 90내지 100℃에서 8~12시간, 바람직하게는 80내지 90℃에서 12~24시간 열수 감압 추출법으로 추출하여 극성 용매에 가용한 복합 생약 추출물을 얻는다. Preferably, the herbal medicines are 5 to 10 times, more preferably 10 to 15 times volume / weight of distilled water, lower alcohols such as ethanol, or a mixed solvent thereof, preferably distilled water alone or a mixed solvent of 30 to 50% water and ethanol. Was added and cooled to 12 hours to 24 hours, preferably 24 hours to 36 hours at 15 ° C. or lower to room temperature, and then 8 to 12 hours at 90 to 100 ° C., preferably 12 to 24 hours at 80 to 90 ° C. Extraction by reduced pressure extraction yields a complex herbal extract available in a polar solvent.

또, 본 발명의 발효조건은 20℃ 이하와 50℃ 이상에서는 발효효율이 적어지므로, 25℃ ~ 40℃에서 15 ~ 20일이 바람직하다. In addition, since the fermentation conditions of the present invention are less than 20 ℃ and 50 ℃ or more fermentation efficiency, 15 to 20 days is preferable at 25 ℃ to 40 ℃.

상기 발효과정 단계로부터 수득한 발효액을 여과한 후, 이를 60 내지 80℃에서 감압농축 하여 얻어진 엑스를 제조공정으로부터 얻어질 수 있다.After filtering the fermentation broth obtained from the fermentation step, it can be obtained from the manufacturing process X obtained by concentration under reduced pressure at 60 to 80 ℃.

본 발명은 생약재를 혼합하여 동시에 추출하거나 또는 각각을 따로 추출하여 혼합할 수도 있다.In the present invention, the herbal medicines may be mixed and extracted at the same time or may be separately extracted and mixed.

본 발명의 생약조성물은 통상적으로 사용되는 부형제, 붕해제, 감미제, 활택제, 향미제 등을 추가로 포함할 수 있으며, 통상의 방법에 의해 정제, 캡슐, 과립, 현탁제, 유화제, 시럽제, 액제 또는 비경구투여용 제제와 같은 단위투여용 또는 수회 투여용 약제학적 제제로 제형화 될 수 있다. The herbal composition of the present invention may further include conventionally used excipients, disintegrants, sweeteners, lubricants, flavoring agents, etc., tablets, capsules, granules, suspensions, emulsifiers, syrups, solutions Or in dosage unit or multiple dose pharmaceutical formulations, such as parenteral formulations.

본 발명의 생약조성물은 특정 환자에 대한 투여 용량 수준은 환자의 체중, 연령, 성별, 건강상태, 식이, 투여시간, 투여방법, 배설율, 질환의 중증도 등에 따라 변화될 수 있다.In the herbal composition of the present invention, the dosage level for a particular patient may vary depending on the weight, age, sex, health condition, diet, time of administration, administration method, excretion rate, severity of disease, and the like of the patient.

본 발명에서 관절염이란 모든 종류의 관절염을 의미하고, 그 중 특히 타박성 관절염, 류마티스 관절염, 퇴행성 관절염, 통풍성 관절염, 세균에 의해서 고름이 드는 화농성 관절염과 결핵성 관절염을 의미한다.In the present invention, arthritis means all kinds of arthritis, and among them, especially means bruising arthritis, rheumatoid arthritis, degenerative arthritis, gouty arthritis, purulent arthritis and tuberculosis arthritis that are pulp by bacteria.

기타 본 발명의 조성물은 전신성 홍반성 낭창(systemic lupus erythematosus)와 아밀로이드증(amyloidosis)등의 자가면역질환에도 효과가 있다.Other compositions of the present invention are also effective in autoimmune diseases such as systemic lupus erythematosus and amyloidosis.

본 발명의 생약조성물을 제조하는데 있어서, 발효단계에서는 생약추출액을 쌀밥과 누룩 등을 이용하거나 알코올과 초산균(Acetobacter)류 등으로 발효할 수 있으며, 얻어진 발효액은 원할 경우 감압 농축시킬 수도 있다. In the preparation of the herbal composition of the present invention, in the fermentation step, the herbal extract may be fermented using rice and koji or alcohol and acetic acid bacteria, etc., and the obtained fermentation broth may be concentrated under reduced pressure if desired.

또한 본 발명은 두충, 당기, 창출, 우슬, 위령선 등의 복합 생약을 탄소수 1~4의 저급 알코올로 추출하여 잔류 용매를 제거한 농축추출물을 포함하며, 역시 이렇게 제조한 추출물에 발효공정을 적용할 수 있다.In another aspect, the present invention includes a concentrated extract extracting a compound herbal, such as tofu, pull, creation, dew, gas, etc. with a lower alcohol having 1 to 4 carbon atoms to remove the residual solvent, and can also be applied to the extract prepared so fermentation process have.

누룩(곡자, koji)원료의 종류는 밀, 쌀에 밀가루를 입힌 것을 보통 원료로 하는데 녹두, 찹쌀, 보리 등도 쓰이기도 한다. 효모원은 공기, 도꼬마리, 보릿짚, 볏짚, 뽕나무, 쑥, 상주, 연꽃, 솔대의 잎 여뀌의 어린잎, 솔잎 등이 있다. 원료 외 증자 여부는 볶은 것, 찐 것, 살짝 찐 것, 날밀이 있으며 원료의 입도는 12할부터 미분까지 한다. 원료의 종류에는 뽕나무잎, 쑥, 수유를 달인 즙, 복숭아씨 분 말, 살구씨 분말, 참외분말 등이 있고, 여기에 조효소제를 처리하여 제조한다. 조효소제는 재래누룩의 주 균인 Rhyzopus와 Usami 및 Oryzae 등의 균을 배양하여 당화력을 높인 것으로 자연 누룩의 복잡한 맛과 당화력을 동시에 추구한 것이다.The types of koji (koji) raw materials are wheat and rice coated with wheat flour, and mung bean, glutinous rice and barley are also used. Yeast sources include air, dogweed, barley straw, rice straw, mulberry, wormwood, resident, lotus, young leaves of pine needles and pine needles. Non-raw stocks include roasted, steamed, steamed, and wheat flour, and the raw material has a particle size from 12% to fine powder. Types of raw materials include mulberry leaves, mugwort, lactation decoction, peach seed powder, apricot seed powder, melon powder and the like, which are prepared by treating coenzyme. Coenzyme enhances glycation by cultivating bacteria such as Rhyzopus, Usami and Oryzae, which are the main strains of conventional Nuruk, and simultaneously pursues the complex taste and saccharification of natural Nuruk.

다음의 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 실시예 및 실험예에 한정되는 것은 아니다.The following examples are merely to illustrate the invention, but the content of the invention is not limited to the examples and experimental examples.

실시예 1Example 1

경동시장에서 구입한 생약재, 즉 두충, 당귀 각 40g, 우슬, 창출 각 30g, 위령선 10g, 몰약, 엄나무, 독활, 버드나무 각 10g 을 혼합한 생약재에 증류수 2ℓ를 가하고 90 내지 95℃를 유지하여 8시간 감압 추출하여 여과하여 여액을 분리하였고, 같은 방법으로 2회에 걸쳐 여액을 모아 냉각하고, 여액에 발효주정 5%와 초산균(Acetobacter aceti)를 3%를 가하여 잘 혼합하여 30~35℃로 15일간 발효한 후 여과하여 여액이 75~85℃까지 승온한 후 감압농축 하여 용매를 증발시켜 고형분 63%의 87g의 유동성 엑기스를 얻었다.To the herbal medicines purchased at Gyeongdong Market, namely tofu, 40g each of mulberry, 40g of dew, 30g of each generation, 10g of lichen, 10g of myrrh, myrrh, oak tree, poisonous tree, 10g of each of willow tree, add 2L of distilled water and maintain 90-95 ℃. The filtrate was separated by filtration under reduced pressure and the filtrate was separated. The filtrate was collected and cooled twice in the same manner. 5% of fermented alcohol and 3% of Acetobacter aceti were added to the filtrate. After fermentation for 1 day, the mixture was filtered, the filtrate was heated up to 75-85 ° C, concentrated under reduced pressure, and the solvent was evaporated to obtain 87 g of a fluid extract having a solid content of 63%.

실시예 2Example 2

상기 실시예 1의 혼합 생약제에 증류수 1ℓ와 알코올 1ℓ의 혼합용매를 가하고 90 내지 95℃를 유지하여 8시간 감압 추출하여 여과하여 여액을 분리하였고, 같은 방법으로 2회에 걸쳐 여액을 모아 60~70℃에서 감압농축하여 알코올을 증발시켜 냉각하고, 여액에 발효주정 5%와 초산균(Acetobacter aceti)를 3%를 가하여 잘 혼합하여 30~35℃로 15일간 발효한 후 여과하여 여액이 75~85℃까지 승온한 후 감압농축하여 용매를 증발시켜 고형분 63%의 94g의 유동성 엑기스를 얻었다.A mixed solvent of distilled water and 1 liter of alcohol was added to the mixed herbal medicine of Example 1, and the filtrate was separated by filtration under reduced pressure for 8 hours, maintained at 90 to 95 ° C., and the filtrate was collected twice. Concentrated under reduced pressure at ℃ and evaporated to cool the alcohol, 5% fermented alcohol and acetic acid bacterium (Acetobacter aceti) was added to the filtrate and mixed well, fermented at 30-35 ℃ for 15 days, and filtered and the filtrate was 75-85 ℃ The mixture was heated up to, concentrated under reduced pressure, and the solvent was evaporated to obtain 94 g of a fluid extract having a solid content of 63%.

실시예 3Example 3

상기 실시예 1의 혼합 생약재에 증류수 2ℓ를 가하고 90 내지 95℃를 유지하여 8시간 감압 추출하여 여과하여 여액을 분리하였고, 같은 방법으로 2회에 걸쳐 여액을 모아 냉각하였다. 또한, 재래시장에서 구입한 누룩 30 : 고두밥 70과 이스트 0.2%를 넣고 잘 섞어 공기가 잘 통하는 깨끗한 천으로 덮어 25℃에서 36시간 발효하며 중간에 뒤집기를 1회하고 황녹색 포자가 자라면 이 곡자를 50 내지 60℃에서 건조하였다. 추출액에 건조한 곡자 10%를 가하여 잘 혼합하여 30~35℃로 15일간 발효한 후 압착 여과한 후 여액이 75~85℃까지 승온한 다음 감압농축하여 용매를 증발시켜 고형분 62%의 85g의 유동성 엑기스를 얻었다.2 liters of distilled water was added to the mixed herbal medicine of Example 1, and the filtrate was separated by filtration under reduced pressure for 8 hours, maintained at 90 to 95 ° C., and the filtrate was collected and cooled twice in the same manner. In addition, add koji rice 70 and yeast 0.2% purchased from traditional market, mix well, cover with air-clean cloth, ferment for 36 hours at 25 ℃, and invert once and grow yellow green spores. Was dried at 50-60 ° C. 10% dried grains were added to the extract, mixed well, fermented at 30-35 ° C. for 15 days, filtered and filtered. The filtrate was heated to 75-85 ° C., concentrated under reduced pressure, and the solvent was evaporated. Got.

실시예 4Example 4

상기 실시예 1의 혼합 생약제에 증류수 1ℓ와 알코올 1ℓ의 혼합용매를 가하고 90 내지 95℃를 유지하여 8시간 감압 추출하여 여과하여 여액을 분리하였고, 같은 방법으로 2회에 걸쳐 여액을 모아 냉각하였다. 재래시장에서 구입한 누룩 30 : 고두밥 70과 이스트 0.2%를 넣고 잘 섞어 공기가 잘 통하는 깨끗한 천으로 덮어 25℃에서 36시간 발효하며 중간에 뒤집기를 1회하고 황녹색 포자가 자라면 이 곡자를 50 내지 60℃에서 건조하였다. 추출액에 건조한 곡자 10%를 가하여 잘 혼합 하여 30~35℃로 15일간 발효한 후 압착 여과한 후 여액이 75~85℃까지 승온한 다음 감압농축 하여 용매를 증발시켜 고형분 62%의 91g의 유동성 엑기스를 얻었다.A mixed solvent of 1 liter of distilled water and 1 liter of alcohol was added to the mixed herbal medicine of Example 1, and the filtrate was separated by filtration under reduced pressure for 8 hours, maintained at 90 to 95 ° C., and the filtrate was collected and cooled twice in the same manner. Yeast purchased from traditional market 30: Add 70% of soybean rice and 0.2% of yeast, mix well, cover with airy clean cloth and ferment for 36 hours at 25 ℃. Dried at -60 ° C. 10% dried grains were added to the extract, mixed well, fermented at 30-35 ° C. for 15 days, filtered and filtered. The filtrate was heated to 75-85 ° C., concentrated under reduced pressure, and the solvent was evaporated. Thus, 91 g of liquid extract having a solid content of 91 g was extracted. Got.

본 발명의 생약조성물은 관절염 치료 및 예방에 효과가 있으며, 특히 이의 발효 등의 산물이 관절염 치료에 더욱 효과가 있어서 기존의 화학요법적 치료에 대체하여 부작용이 없으면서 탁월한 효능의 관절염 예방 및 치료제로 사용할 수 있으며, 엑스제, 액제, 환제, 산제, 정제, 과립제, 캅셀제 등으로 제조하여 건강기능식품 및 의약품으로 유용하게 이용할 수 있다. The herbal composition of the present invention is effective in treating and preventing arthritis, and in particular, products such as fermentation thereof are more effective in treating arthritis, and thus, as an alternative to conventional chemotherapeutic treatments, can be used as a preventive and therapeutic agent for arthritis with excellent efficacy without side effects. It can be prepared by the X, liquid, pills, powder, tablets, granules, capsules and the like can be usefully used as health functional foods and medicines.

Claims (3)

두충 수피 20중량%, 당귀 뿌리 20중량%, 우슬 뿌리 15중량%, 창출 뿌리줄기 15중량%, 위령선 뿌리 10중량%, 몰약 5중량%, 엄나무 줄기의 속껍질 5중량%, 독활 5중량% 및 버드나무 수피 5중량%를 동시에 추출하거나 또는 각각 추출하여 발효시킨 것임을 특징으로 하는 관절염 치료 및 예방용 생약조성물. 20% by weight bark bark, 20% by weight of Angelica root, 15% by weight of root root, 15% by weight of rhizome root, 10% by weight of lichen root, 5% by weight of myrrh, 5% by weight of bark of oak stem, 5% by weight of poison and bud Herbal composition for the treatment and prevention of arthritis, characterized in that the fermented by simultaneously extracting or 5% by weight of the bark of each tree. 두충 수피 20중량%, 당귀 뿌리 20중량%, 우슬 뿌리 15중량%, 창출 뿌리줄기 15중량%, 위령선 뿌리 10중량%, 몰약 5중량%, 엄나무 줄기의 속껍질 5중량%, 독활 5중량% 및 버드나무 수피 5중량%를 동시에 추출하거나 또는 각각 추출하여 혼합하는 생약추출단계 및 얻어진 추출액의 발효단계를 포함하는 관절염 치료 및 예방용 생약조성물의 제조방법. 20% by weight bark bark, 20% by weight of Angelica root, 15% by weight of root root, 15% by weight of rhizome root, 10% by weight of lichen root, 5% by weight of myrrh, 5% by weight of bark of oak stem, 5% by weight of poison and bud A method of producing a herbal composition for treating and preventing arthritis, comprising extracting the herbal bark at the same time or extracting and mixing 5% by weight of bark at the same time. 제 2 항에 있어서, 상기 발효단계에서 발효된 추출액을 농축하는 단계를 더 포함하는 생약조성물의 제조방법. The method of claim 2, further comprising the step of concentrating the extract fermented in the fermentation step.
KR1020070053892A 2007-06-01 2007-06-01 Herb composition useful for arthritis treatment or prevention and preparation thereof KR20080105825A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020070053892A KR20080105825A (en) 2007-06-01 2007-06-01 Herb composition useful for arthritis treatment or prevention and preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020070053892A KR20080105825A (en) 2007-06-01 2007-06-01 Herb composition useful for arthritis treatment or prevention and preparation thereof

Publications (1)

Publication Number Publication Date
KR20080105825A true KR20080105825A (en) 2008-12-04

Family

ID=40367046

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020070053892A KR20080105825A (en) 2007-06-01 2007-06-01 Herb composition useful for arthritis treatment or prevention and preparation thereof

Country Status (1)

Country Link
KR (1) KR20080105825A (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101136463B1 (en) * 2010-03-29 2012-04-19 김진우 Health food with myrrh and its manufacturing method
CN102657825A (en) * 2012-06-01 2012-09-12 通化金马药业集团股份有限公司 Rheumatic pain-relieving medicine used for treating rheumatic arthritis and rheumatoid arthritis and preparation method thereof
CN102908394A (en) * 2012-11-20 2013-02-06 韩永芳 Chinese medicament for activating promoting blood circulation to remove blood stasis and relieving pains
CN102935119A (en) * 2012-11-21 2013-02-20 吉林鑫水科技开发有限公司 Method for preparing ointment for treating lumbar disc herniation
KR101251207B1 (en) * 2011-03-11 2013-04-08 어봉우 A method for preparing a pill or granule type fermented composition comprising the extract of complex herb useful in treating rheumatic disease
CN103083485A (en) * 2012-11-11 2013-05-08 李传深 Externally applied agent for treating heel spur
CN103655871A (en) * 2013-12-17 2014-03-26 广州白云山陈李济药厂有限公司 Application of traditional Chinese medicine composition in preparation of drug for treating osteoarthritis
CN104173511A (en) * 2014-08-29 2014-12-03 赵翠燕 Medicine for treating osteoarthritis
CN104435994A (en) * 2014-12-22 2015-03-25 蒋亚静 Traditional Chinese medicine for treating hyperosteogeny arthritis and preparation method thereof
KR20170091535A (en) * 2016-02-01 2017-08-09 이강헌 Composition for preventing or treating osteoarthritis containing an extract of Angelica gigas Nakai
KR102007144B1 (en) 2019-04-26 2019-08-02 에스케이바이오랜드 주식회사 A novel strain of Lactobacillus plantarum SKB1234 having an improving effect on arthritis and a method for producing a mixture of the fermented Achyranthes japonica Nakai extract using the Lactobacillus plantarum SKB1234, Angelica gigas Nakai extract and Eucommia ulmoides Oliver extract
KR102044659B1 (en) 2019-04-26 2019-11-13 에스케이바이오랜드 주식회사 Comprising composition of fermented Achyranthes japonica Nakai extract Complex for preventing or treating arthritis

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101136463B1 (en) * 2010-03-29 2012-04-19 김진우 Health food with myrrh and its manufacturing method
KR101251207B1 (en) * 2011-03-11 2013-04-08 어봉우 A method for preparing a pill or granule type fermented composition comprising the extract of complex herb useful in treating rheumatic disease
CN102657825A (en) * 2012-06-01 2012-09-12 通化金马药业集团股份有限公司 Rheumatic pain-relieving medicine used for treating rheumatic arthritis and rheumatoid arthritis and preparation method thereof
CN103083485A (en) * 2012-11-11 2013-05-08 李传深 Externally applied agent for treating heel spur
CN102908394A (en) * 2012-11-20 2013-02-06 韩永芳 Chinese medicament for activating promoting blood circulation to remove blood stasis and relieving pains
CN102935119A (en) * 2012-11-21 2013-02-20 吉林鑫水科技开发有限公司 Method for preparing ointment for treating lumbar disc herniation
CN103655871A (en) * 2013-12-17 2014-03-26 广州白云山陈李济药厂有限公司 Application of traditional Chinese medicine composition in preparation of drug for treating osteoarthritis
CN104173511A (en) * 2014-08-29 2014-12-03 赵翠燕 Medicine for treating osteoarthritis
CN104435994A (en) * 2014-12-22 2015-03-25 蒋亚静 Traditional Chinese medicine for treating hyperosteogeny arthritis and preparation method thereof
KR20170091535A (en) * 2016-02-01 2017-08-09 이강헌 Composition for preventing or treating osteoarthritis containing an extract of Angelica gigas Nakai
US10688144B2 (en) 2016-02-01 2020-06-23 Kang Hyun Lee Composition for preventing or treating osteoarthritis containing an extract of Angelica gigas Nakai
KR102007144B1 (en) 2019-04-26 2019-08-02 에스케이바이오랜드 주식회사 A novel strain of Lactobacillus plantarum SKB1234 having an improving effect on arthritis and a method for producing a mixture of the fermented Achyranthes japonica Nakai extract using the Lactobacillus plantarum SKB1234, Angelica gigas Nakai extract and Eucommia ulmoides Oliver extract
KR102044659B1 (en) 2019-04-26 2019-11-13 에스케이바이오랜드 주식회사 Comprising composition of fermented Achyranthes japonica Nakai extract Complex for preventing or treating arthritis

Similar Documents

Publication Publication Date Title
KR20080105825A (en) Herb composition useful for arthritis treatment or prevention and preparation thereof
Al-Snafi Traditional uses of Iraqi medicinal plants (part 2)
Lakhdari et al. Ethnobotanical study of some plants used in traditional medicine in the region of Oued Righ (Algerian Sahara)
Khare Indian herbal remedies: rational Western therapy, ayurvedic, and other traditional usage, Botany
Guarino et al. Ethnobotanical study of the Sannio area, Campania, southern Italy
Panda Handbook on medicinal herbs with uses: medicinal plant farming, most profitable medicinal plants in India, medicinal plants farming in India, plants used in herbalism, medicinal herbs you can grow, medicinal herbs and their uses, medicinal herbs, herbal & medicinal plants, growing medicinal herb, most profitable medicinal herbs growing with small investment, herbal medicine herbs
CN101049424B (en) Medication for treating infection in respiratory system
Priya et al. Phyllanthus emblica Linn.(Amla)—a natural gift to humans: an overview
CN113499393B (en) Composition with gastric mucosa injury protection effect and preparation method thereof
Chand et al. Assessment of ethnomedicinal plant diversity of Una and Hamirpur district of Himachal Pradesh, India: an ethno-ecological approach
KR101442141B1 (en) Herbal medicine composition for anti-cancer and forms thereof
CN107617061A (en) A kind of composition with clearing lung-heat moistening lung function and preparation method thereof
Pattanayak Healthcare system using succulent parts of plants
De Medicinal and aromatic plants of North-East India
CN101485701B (en) Method for preparing total polyphenol of Loropetalum chinense (R. Br.) Oliver for treating burn and scald
KR101479096B1 (en) Health functional food comprising extracts of herbal mixture for preventing or improving edema of delivered or pregnant woman
CN103446564B (en) Chinese medicine composition of a kind of anti-inflammation and preparation method thereof
EP1708789B1 (en) Herbal composition for gastrointestinal disorders
EP2680924B1 (en) A novel herbal composition for the treatment of kidney stone and other urinary tract disorders
CN111686165A (en) Pure traditional Chinese medicine composition for relieving itching of private parts, preparation and application of pure traditional Chinese medicine composition in cleaning private parts
RU2303993C1 (en) Treatment and prophylaxis means applicable for treating young agricultural animals and method for preventing and treating calves for gastrointestinal tract diseases
Tewari et al. Medicinal use of some common plants among people of Garur Block of district Bageshwar, Uttarakhand, India
KR20030079289A (en) The carbonated soft drinks a manufacturing process and a composition of ling indigestion hangover cures.
JP2000236836A (en) Food prepared by using koto-sugi as main raw material and its preparation
US20130177597A1 (en) Mango seed herbal medication

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid